收藏切换
Changes of hemoglobin level in patients with baritinib-associated rheumatoid arthritis
收藏切换
Huan LIU1, Wei LIU1, Lu ZHAO1, Yuting CAO2
World Clinical Drug | 2023, 44(11) : 1174 - 1178
Less
收藏切换
World Clinical Drug | 2023, 44(11): 1174-1178
• Article •
Changes of hemoglobin level in patients with baritinib-associated rheumatoid arthritis
Full
Huan LIU1, Wei LIU1, Lu ZHAO1, Yuting CAO2
Affiliations
  • 1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China
  • 2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Published: 2023-11-10 doi: 10.13683/j.wph.2023.11.007
Outline
收藏切换
Objective

To observe the effects of baritinib on haemoglobin (Hb) levels in patients with rheumatoid arthritis (RA) with moderate to high disease activity.

Methods

RA patients receiving biologics or targeted synthetic drugs admitted to the Department of Arthropathy of Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine from September 2021 to May 2023 were retrospectively included. During the study, 60 patients were enrolled in the baritinib group, and the tumor necrosis factor inhibitor (TNFi) group was matched by random selection at the ratio of 1:1, so 60 patients in each group. The clinical information of all patients at baseline and 12-week follow-up period were collected, and the changes of Hb levels were monitored.

Results

After treatment, 42 patients in TNFi group and 45 patients in baritinib group reached the therapeutic effect standard, and there was no statistical significance between the two groups (P>0.05). After 12 weeks of treatment, Hb level in bariatinib group was higher than that before treatment, and there was no significant difference between responders and non-responders (P>0.05). After treatment, Hb level in patients with anemia at baseline increased by 8.21 g/L, while that in those without anemia increased by 0.66 g/L, with statistical significance (P<0.05).

Conclusion

The efficacy of baritinib in the treatment of moderate to high disease activity RA is comparable to that of TNFi. Baritinib can improve anemia in RA patients by reducing inflammation, and Hb levels in patients with baseline anemia increased significantly after 12 weeks of treatment, and the extent of increase was significantly higher than that in patients without baseline anemia.

baritinib  /  rheumatoid arthritis  /  hemoglobin
刘欢, 刘薇, 赵璐, 曹宇婷. 巴瑞替尼相关类风湿性关节炎患者血红蛋白水平变化观察. 世界临床药物, 2023 , 44 (11) : 1174 -1178 . DOI: 10.13683/j.wph.2023.11.007
Huan LIU, Wei LIU, Lu ZHAO, Yuting CAO. Changes of hemoglobin level in patients with baritinib-associated rheumatoid arthritis[J]. World Clinical Drug, 2023 , 44 (11) : 1174 -1178 . DOI: 10.13683/j.wph.2023.11.007
Year 2023 volume 44 Issue 11
9
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.11.007
  • Receive Date:2023-08-22
  • Online Date:2026-11-18
  • Published:2023-11-10
Article Data
Affiliations
History
  • Received:2023-08-22
Affiliations
    1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China
    2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.11.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT